Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-167 |
Sentence |
denotes |
Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case Series. |
T1 |
0-167 |
Sentence |
denotes |
Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case Series. |
T2 |
168-181 |
Sentence |
denotes |
INTRODUCTION: |
T2 |
168-181 |
Sentence |
denotes |
INTRODUCTION: |
T3 |
182-377 |
Sentence |
denotes |
Severe coronavirus disease 2019 (COVID-19) is characterised by hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially acute respiratory distress syndrome (ARDS). |
T3 |
182-377 |
Sentence |
denotes |
Severe coronavirus disease 2019 (COVID-19) is characterised by hyperinflammatory state, systemic coagulopathies, and multiorgan involvement, especially acute respiratory distress syndrome (ARDS). |
T4 |
378-585 |
Sentence |
denotes |
We here describe our preliminary clinical experience with COVID-19 patients treated via an early initiation of extracorporeal blood purification combined with systemic heparinisation and respiratory support. |
T4 |
378-585 |
Sentence |
denotes |
We here describe our preliminary clinical experience with COVID-19 patients treated via an early initiation of extracorporeal blood purification combined with systemic heparinisation and respiratory support. |
T5 |
586-594 |
Sentence |
denotes |
METHODS: |
T5 |
586-594 |
Sentence |
denotes |
METHODS: |
T6 |
595-695 |
Sentence |
denotes |
Fifteen patients were included; several biomarkers associated with COVID-19 severity were monitored. |
T6 |
595-695 |
Sentence |
denotes |
Fifteen patients were included; several biomarkers associated with COVID-19 severity were monitored. |
T7 |
696-919 |
Sentence |
denotes |
Personalised treatment was tailored according to the levels of interleukin (IL)-6, IL- 8, tumour necrosis factor alpha, C-reactive protein (CRP), neutrophilto- lymphocyte ratio, thrombocyte counts, D-dimers, and fibrinogen. |
T7 |
696-919 |
Sentence |
denotes |
Personalised treatment was tailored according to the levels of interleukin (IL)-6, IL- 8, tumour necrosis factor alpha, C-reactive protein (CRP), neutrophilto- lymphocyte ratio, thrombocyte counts, D-dimers, and fibrinogen. |
T8 |
920-1109 |
Sentence |
denotes |
Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds. |
T8 |
920-1109 |
Sentence |
denotes |
Treatment consisted of respiratory support, extracorporeal blood purification using the AN69ST (oXiris®) hemofilter, and 300 U/kg heparin to maintain activation clotting time ≥ 180 seconds. |
T9 |
1110-1118 |
Sentence |
denotes |
RESULTS: |
T9 |
1110-1118 |
Sentence |
denotes |
RESULTS: |
T10 |
1119-1301 |
Sentence |
denotes |
Ten patients presented with severe to critical disease (dyspnoea, hypoxia, respiratory rate > 30/min, peripheral oxygen saturation < 90%, or > 50% lung involvement on X-ray imaging). |
T10 |
1119-1301 |
Sentence |
denotes |
Ten patients presented with severe to critical disease (dyspnoea, hypoxia, respiratory rate > 30/min, peripheral oxygen saturation < 90%, or > 50% lung involvement on X-ray imaging). |
T11 |
1302-1450 |
Sentence |
denotes |
The median intensive care unit length of stay was 9.3 days (interquartile range 5.3-10.1); two patients developed ARDS and died after 5 and 26 days. |
T11 |
1302-1450 |
Sentence |
denotes |
The median intensive care unit length of stay was 9.3 days (interquartile range 5.3-10.1); two patients developed ARDS and died after 5 and 26 days. |
T12 |
1451-1629 |
Sentence |
denotes |
Clinical improvement was associated with normalisation (increase) of thrombocytes and white blood cells, stable levels of IL-6 (< 50 ng/mL), and a decrease of CRP and fibrinogen. |
T12 |
1451-1629 |
Sentence |
denotes |
Clinical improvement was associated with normalisation (increase) of thrombocytes and white blood cells, stable levels of IL-6 (< 50 ng/mL), and a decrease of CRP and fibrinogen. |
T13 |
1630-1641 |
Sentence |
denotes |
CONCLUSION: |
T13 |
1630-1641 |
Sentence |
denotes |
CONCLUSION: |
T14 |
1642-1835 |
Sentence |
denotes |
Continuous monitoring of COVID-19 severity biomarkers and radiological imaging is crucial to assess disease progression, uncontrolled inflammation, and to avert irreversible multiorgan failure. |
T14 |
1642-1835 |
Sentence |
denotes |
Continuous monitoring of COVID-19 severity biomarkers and radiological imaging is crucial to assess disease progression, uncontrolled inflammation, and to avert irreversible multiorgan failure. |
T15 |
1836-2054 |
Sentence |
denotes |
The combination of systemic heparin anticoagulation regimens and extracorporeal blood purification using cytokine-adsorbing hemofilters may reduce hyperinflammation, prevent coagulopathy, and support clinical recovery. |
T15 |
1836-2054 |
Sentence |
denotes |
The combination of systemic heparin anticoagulation regimens and extracorporeal blood purification using cytokine-adsorbing hemofilters may reduce hyperinflammation, prevent coagulopathy, and support clinical recovery. |